26
|
Torrente S, Andreani S, Badenchini F, Rancati T, Marenghi C, Avuzzi B, Morlino S, Bedini N, Villa S, Noris Chiorda B, Palorini F, Andreoli L, Di Florio T, Catanzaro M, Stagni S, Biasoni D, Torelli T, Tesone A, Nicolai N, Valdagni R. Clinical Results for an Active Surveillance Cohort with Localized Prostate Cancer Receiving RT after Exiting Active Surveillance. Int J Radiat Oncol Biol Phys 2018. [DOI: 10.1016/j.ijrobp.2018.07.282] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
27
|
Gabriele P, Avuzzi B, Sanguineti G, Maggio A, Giandini T, Landoni V, Munoz F, Migliaccio F, Cante D, Petrucci E, Vavassori V, Villa E, Waskiewicz J, Farina P, Farina B, Girelli G, Improta I, Badenchini F, Noris Chiorda B, Carillo V, Sini C, Valdagni R, Fiorino C, Rancati T, Cozzarini C. PO-0826: Factors affecting self-reported, long-term (1-2 yrs) urinary incontinence from post-prostatectomy RT. Radiother Oncol 2018. [DOI: 10.1016/s0167-8140(18)31136-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
28
|
Noris Chiorda B, Gabriele P, Munoz F, Garibaldi E, Migliaccio F, Faiella A, Giordano C, Cante D, Petrucci E, Avuzzi B, Giandini T, Villa E, Salmoiraghi P, Girelli G, Farina B, Waskiewicz J, Farina P, Gaetano M, Carillo V, Sacco V, Bianconi C, Badenchini F, Fiorino C, Rancati T, Cozzarini C. PO-0820: The bowel syndrome after whole pelvis RT for prostate cancer: acute symptoms and quality of life. Radiother Oncol 2018. [DOI: 10.1016/s0167-8140(18)31130-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
29
|
Cozzarini C, Noris Chiorda B, Fiorino C, Pasetti M, Briganti A, Deantoni C, Deli A, Fodor A, Fossati N, Gandaglia G, Sini C, Montorsi F, Di Muzio N. PO-0730: The independent benefit deriving from high doses and WPRT in salvage post-prostatectomy radiotherapy. Radiother Oncol 2017. [DOI: 10.1016/s0167-8140(17)31167-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
30
|
Di Muzio N, Fodor A, Deantoni C, Noris Chiorda B, Broggi S, Mangili P, Dell'Oca I, Chiara A, Passoni P, Slim N, Pasetti M, Calandrino R, Cozzarini C, Fiorino C. EP-1318: Is hypofractionation combined to WPRT effective in high risk prostate cancer patients? Radiother Oncol 2017. [DOI: 10.1016/s0167-8140(17)31753-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
31
|
Noris Chiorda B, Garibaldi E, Saracino B, Cante D, Avuzzi B, Villa E, Waskiewicz J, Gaetano M, Munoz F, Girelli G, Sini C, Rancati T, Badenchini F, Bianconi C, Fiorino C, Cozzarini C. PO-0727: Acute intestinal toxicity after whole-pelvis IMRT for prostate cancer from the patient’s perspective. Radiother Oncol 2017. [DOI: 10.1016/s0167-8140(17)31164-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
32
|
Slim N, Noris Chiorda B, Gumina C, Cattaneo G, Reni M, Aldrighetti L, Deli A, Zerbetto F, Passoni P, Di Muzio N. PO-0694: Post-operative Intensity-Modulated hypofractionated Image-Guided Radiotherapy in cholangiocarcinoma. Radiother Oncol 2017. [DOI: 10.1016/s0167-8140(17)31131-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
33
|
Pasetti M, Fodor A, Sini C, Zerbetto F, Mangili P, Signorotto P, Dell’Oca I, Gumina C, Azizi M, Deli A, Passoni P, Slim N, Deantoni C, Noris Chiorda B, Foti S, Chiara A, Rossi G, Fiorino C, Bolognesi A, Di Muzio N. EP-1159: Hypofractionated adjuvant radiotherapy and concomitant trastuzumab for breast cancer: 5-year results. Radiother Oncol 2017. [DOI: 10.1016/s0167-8140(17)31595-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
34
|
Sini C, Noris Chiorda B, Gabriele P, Sanguineti G, Morlino S, Badenchini F, Cante D, Carillo V, Gaetano M, Giandini T, Landoni V, Maggio A, Perna L, Petrucci E, Sacco V, Valdagni R, Rancati T, Fiorino C, Cozzarini C. PO-0846: Bowel dose-volume relationship for patientreported acute intestinal toxicity from pelvic IMRT. Radiother Oncol 2017. [DOI: 10.1016/s0167-8140(17)31283-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
35
|
Fodor A, Sini C, Deantoni C, Fiorino C, Cozzarini C, Noris Chiorda B, Dell'Oca I, Picchio M, Mangili P, Incerti E, Calandrino R, Gianolli L, Di Muzio N. EP-1315: Prostate cancer lymph nodal disease: SBRT only or extensive prophylactic irradiation and boost? Radiother Oncol 2017. [DOI: 10.1016/s0167-8140(17)31750-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
36
|
Sacco V, Viale A, Noris Chiorda B, Sini C, Salvadori G, Fiorino C, Di Muzio N, Cozzarini C. EP-1815: Technical aspects and setup irradiation of rats using a clinical accelerator. Radiother Oncol 2017. [DOI: 10.1016/s0167-8140(17)32178-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
37
|
Fallara G, Benigni F, Cozzarini C, Noris Chiorda B, Sini C, Perani L, Spinelli A, Venturini M, Salonia A, Briganti A, Montorsi F, Di Muzio N, Fiorino C. OC-0222: GnRH receptor blockade reduces radiation-induced bladder toxicity: first evidence in a rat model. Radiother Oncol 2017. [DOI: 10.1016/s0167-8140(17)30665-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
38
|
Chiorda BN, Sini C, Fiorino C, Badenchini F, Briganti A, Chiara A, Deantoni C, Slim N, Suardi N, Montorsi F, Di Muzio N, Cozzarini C. PO-0749: Factors predicting late severe urinary incontinence after postprostatectomy RT: a longitudinal study. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)31999-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
39
|
Sini C, Fiorino C, Perna L, Noris Chiorda B, Sacco V, Pasetti M, Chiara A, Calandrino R, Di Muzio N, Cozzarini C. EP-1725: Predictors of diarrhea after whole-pelvis post-prostatectomy radiotherapy. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)32976-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
40
|
Deantoni C, Cozzarini C, Fodor A, Noris Chiorda B, Mangili P, Picchio M, Incerti E, Dell'Oca I, Passoni P, Fiorino C, Calandrino R, Di Muzio N. EP-1347: Could “radical” RT be a reasonable choice in bone oligometastatic prostate cancer patients? Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)32597-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
41
|
Di Muzio NG, Fodor A, Noris Chiorda B, Broggi S, Mangili P, Valdagni R, Dell'Oca I, Pasetti M, Deantoni CL, Chiara A, Berardi G, Briganti A, Calandrino R, Cozzarini C, Fiorino C. Moderate Hypofractionation with Simultaneous Integrated Boost in Prostate Cancer: Long-term Results of a Phase I-II Study. Clin Oncol (R Coll Radiol) 2016; 28:490-500. [PMID: 26961088 DOI: 10.1016/j.clon.2016.02.005] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/13/2015] [Revised: 01/18/2016] [Accepted: 01/19/2016] [Indexed: 10/22/2022]
Abstract
AIMS To report 5 year outcome and late toxicity in prostate cancer patients treated with image-guided tomotherapy with a moderate hypofractionated simultaneous integrated boost approach. MATERIALS AND METHODS In total, 211 prostate cancer patients, 78 low risk, 53 intermediate risk and 80 high risk were treated between 2005 and 2011. Intermediate- and high-risk patients received 51.8 Gy to pelvic lymph nodes and concomitant simultaneous integrated boost to prostate up to 74.2 Gy/28 fractions, whereas low-risk patients were treated to the prostate only with 71.4 Gy/28 fractions. Daily megavoltage computed tomography (MVCT) image guidance was applied. Androgen deprivation was prescribed for a median duration of 6 months for low-risk patients (for downsizing), 12 months for intermediate-risk and 36 months for high-risk patients. The 5 year biochemical relapse-free survival (bRFS), cancer-specific survival (CSS), overall survival and late gastrointestinal and genitourinary CTCAE.v3 toxicity were assessed. The effect of several clinical variables on both outcome and gastrointestinal/genitourinary toxicity was tested by uni- and multivariate Cox regression analyses. RESULTS After a median follow-up of 5 years, the late toxicity actuarial incidence was: genitourinary ≥ grade 2: 20.2%; genitourinary ≥ grade 3: 5.9%; gastrointestinal ≥ grade 2: 17%; gastrointestinal ≥ grade 3: 6.3% with lower prevalence at the last follow-up visit (≥ grade 3: genitourinary: 1.9%; gastrointestinal: 1.9%). Major predictors of ≥ grade 3 genitourinary and gastrointestinal late toxicity were genitourinary acute toxicity ≥ grade 2 (hazard ratio: 4.9) and previous surgery (hazard ratio: 3.4). The overall 5 year bRFS was 93.7% (low risk: 94.6%; intermediate risk: 96.2%; high risk: 91.1%), overall survival and CSS were 88.6% (low risk: 90.5%; intermediate risk: 87.4%; high risk: 87%) and 97.5% (low risk: 98.7%; intermediate risk: 95%; high risk: 94.3%), respectively. Risk classes and androgen deprivation were not significantly correlated with either bRFS, overall survival or CSS. Twelve patients experienced a biochemical relapse but none experienced clinically proven local and/or pelvic recurrence. CONCLUSION A satisfactory 5 year outcome with an acceptable toxicity profile was observed. The combination of image-guided radiotherapy-intensity-modulated radiotherapy, high equivalent 2 Gy dose (EQD2) with a moderate hypofractionated approach and extensive prophylactic lymph node irradiation also leads to very good outcome in high-risk patients.
Collapse
|
42
|
Fossati N, Karnes J, Morlacco A, Moschini M, Boorjian S, Seisen T, Bossi A, Cozzarini C, Fiorino C, Noris Chiorda B, Gandaglia G, Tosco L, De Ridder D, Joniau S, Goldner G, Shariat S, Hinkelbein W, Haustermans K, Tombal B, Montorsi F, Van Poppel H, Wiegel T, Briganti A. 544 Long-term impact of adjuvant versus early salvage radiation therapy on clinical recurrence in pT3N0 prostate cancer patients treated with radical prostatectomy: Results of a multi-institutional analysis. ACTA ACUST UNITED AC 2016. [DOI: 10.1016/s1569-9056(16)60546-8] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
43
|
Di Muzio N, Fodor A, Cozzarini C, Broggi S, Chiorda BN, Pasetti M, Briganti A, Valdagni R, Calandrino R, Fiorino C. Five-Year Outcomes and Late Toxicity in Prostate Cancer Patients Treated With Moderate Hypofractionated Helical Tomotherapy and Simultaneous Integrated Boost in a Phase 1-2 Study. Int J Radiat Oncol Biol Phys 2015. [DOI: 10.1016/j.ijrobp.2015.07.1094] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
44
|
Chiorda BN, Blanchard P, Calmels L, Patard J, Baumert H, Moussier A, Fizazi K, Champoudry J, Bossi A. A Dose-Escalation Study for High-Dose-Rate Brachytherapy Boost in Intermediate- and High-Risk Prostate Cancer Patients. Int J Radiat Oncol Biol Phys 2015. [DOI: 10.1016/j.ijrobp.2015.07.1148] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
45
|
Mondino A, Lazarevic D, Fiorino C, Briganti A, Deantoni C, Fodor A, Noris Chiorda B, Passoni P, Sacco V, Sini C, Montorsi F, Di Muzio N, Cozzarini C. EP-1230: The level of lymphopenia inversely correlates with the risk for late urinary toxicity after WPRTfor prostate cancer. Radiother Oncol 2015. [DOI: 10.1016/s0167-8140(15)41222-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
46
|
Sacco V, Sini C, Perna L, Deantoni C, Noris Chiorda B, Fiorino C, Cozzarini C, Salvadori G, Calandrino R, Di Muzio N. EP-1627: Inter-observer variability of intestinal loops delineation after whole pelvis radiotherapy for prostate patients. Radiother Oncol 2015. [DOI: 10.1016/s0167-8140(15)41619-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
47
|
Sini C, Fiorino C, Noris Chiorda B, Chiara A, Deantoni C, Gumina C, Perna L, Sbalchiero A, Calandrino R, Di Muzio N, Cozzarini C. PD-0530: Predictors of hematological toxicity after whole-pelvis intensity-modulated post-prostatectomy radiotherapy. Radiother Oncol 2015. [DOI: 10.1016/s0167-8140(15)40525-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
48
|
Cozzarini C, Zuppardi F, Fiorino C, Briganti A, Fodor A, Naimo S, Noris Chiorda B, Pasetti M, Slim N, Suardi N, Sarno L, Montorsi F, Di Muzio N. OC-0321: Impact of urinary symptoms and incontinence on anxiety and depression 1 year after postprostatectomy radiotherapy. Radiother Oncol 2015. [DOI: 10.1016/s0167-8140(15)40319-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
49
|
Di Muzio N, Fodor A, Noris Chiorda B, Cozzarini C, Broggi S, Mangili P, Valdagni R, Dell'Oca I, Pasetti M, Deantoni C, Chiara A, Berardi G, Briganti A, Calandrino R, Fiorino C. PO-0719: Excellent 5 year outcome with image guided moderate hypofractionation in prostate cancer : phase I-II study results. Radiother Oncol 2015. [DOI: 10.1016/s0167-8140(15)40711-x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
50
|
Noris Chiorda B, Cozzarini C, Fiorino C, Briganti A, Berardi G, Pasetti M, Sbalchiero A, Suardi N, Zerbetto F, Di Muzio N. PD-0306: Factors influencing urinary incontinence following post-prostatectomy IMRT irradiation. A prospective study. Radiother Oncol 2014. [DOI: 10.1016/s0167-8140(15)30411-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|